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ABSTRACT	  
	  
Background:	  There	  has	  been	  a	  concern	  regarding	  the	  masking	  of	  vitamin	  B-­‐12	  deficiency	  in	  the	  post-­‐fortification	  period	  (after	  January	  1,	  1998).	  	  
Objective:	  The	  objective	  of	  this	  study	  was	  to	  investigate	  the	  potential	  masking	  of	  vitamin	  B-­‐12	  deficiency	  by	  comparing	  the	  proportion	  of	  individuals	  with	  low	  serum	  B-­‐12	  without	  macrocytosis	  between	  pre-­‐	  and	  post-­‐fortification	  periods	  using	  data	  from	  the	  National	  Health	  and	  Nutrition	  Examination	  Survey	  (NHANES).	  	  	  
Methods:	  The	  study	  included	  7242	  individuals	  from	  NHANES	  III	  (pre-­‐fortification	  group)	  and	  combined	  NHANES	  1999-­‐2000,	  2001-­‐2002,	  2003-­‐2004,	  2005-­‐2006	  (post-­‐fortification	  group).	  Vitamin	  B-­‐12	  deficiency	  and	  macrocytosis	  were	  defined	  as	  having	  <148	  pmol/L	  of	  serum	  vitamin	  B-­‐12	  and	  mean	  corpuscular	  volume	  (MCV)	  of>98	  fL,	  respectively.	  A	  multivariate	  logistic	  regression	  was	  performed	  to	  estimate	  the	  likelihood	  of	  being	  low	  serum	  B-­‐12	  without	  macrocytosis	  in	  the	  post-­‐fortification	  period	  in	  relation	  to	  the	  pre-­‐fortification	  period.	  	  
Results:	  Between	  pre-­‐	  and	  post-­‐fortification	  periods,	  there	  was	  no	  significant	  difference	  in	  the	  proportion	  of	  individuals	  with	  low	  serum	  vitamin	  B-­‐12	  without	  macrocytosis.	  However,	  odds	  of	  having	  low	  serum	  vitamin	  B-­‐12	  without	  macrocytosis	  in	  the	  post	  fortification	  era	  increased	  in	  men	  (OR=2.65,	  1.24-­‐5.65),	  non-­‐Hispanic	  blacks	  (OR=3.12,	  1.04-­‐9.35),	  Non-­‐smokers	  (OR=4.63, 1.90-11.27), and 
	  	  
those aged 55 and older (OR=2.183, 1.01-4.74) compared their respective counterparts in 
the pre-fortification period. 
 
Conclusions: No significant difference in the proportion of individuals with vitamin B-
12 deficiency without macrocytosiss was seen between the pre and post-fortification 
periods suggesting no making of vitamin B-12 deficiency. In the post-fortification period, 
serum folate was found to be a predictor of the masking effect. The impact of increased 
folic acid intake in the post-fortification period needs to be evaluated on a periodic basis 
especially, in non-target population.  
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CHAPTER I 
INTORDUCTION 
 
Topic and problem 
 Neural tube defects (NTDs) are linked to folate deficiency in the first trimester of 
pregnancy, and include occur during the closing of the neural tube of the developing 
embryo. The cell membranes of the neural crest and neuroepithelial cells of the embryo 
have high expressions of folate-binding protein 1 (Folr1).1 This indicates high affinity 
and demand for folate within these cells. Without adequate folate, these cells do not 
invaginate and fuse properly.2 Depending on the specific location of the failed closure, 
different NTDs occur. Spina bifida is the improper closing of the tail end of the neural 
tube and results in developmental problems of the spinal column, typically with the spinal 
cord left unprotected and exposed. Anencephaly occurs when the head of the neural tube 
fails to close, resulting in improper brain and cranial development. Most babies born with 
anencephaly do not survive.3  
 Education programs were designed and implemented to increase folic acid 
consumption among reproductive age females in the United States, however there was 
little impact on reducing the number of NTD.3 As a result, and after careful 
consideration, the Food and Drug Administration (FDA) mandated fortification of 
processed grains products in the United States with folic acid effective January 1st 1998. 
Other countries, including Chile, Canada, and Australia quickly followed suit. Ultimately 
these programs are credited with a decrease in the prevalence of NTD by as much as 46%
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worldwide.1 In the United States, the rate of NTD decreased by 19% after fortification. 
Spina bifida rates in the United States decreased from 26.2 to 20.2 per 100,000 live 
births, and anencephaly decreased from 11.6 to 10.3 per 100,000 live births.4 Despite the 
positive benefits of the fortification programs, the Institute of Medicine identified a 
potential risk of deleterious neurological effects may increase when a deficiency in 
vitamin B-12 is masked by increased folic acid consumption.5Folic acid and Vitamin B-
12 are linked at one conversion reaction within the folate-cycle. At this junction vitamin 
B-12, also known as cobalamin, acts as a methyl-group transfer molecule and is critical in 
creating the necessary substrates for methylation reactions. Methylation is an important 
biochemical process that creates substrates necessary for DNA synthesis, myelination of 
neurons, regulation of gene expression, and protein synthesis.6 In this complex, multi-
step process, vitamin B-12 and folic acid play a pivotal role in creating the methyl-donor 
substrate methylene tetrahydrofolate (methylene THF). In its role as a coenzyme with 
methionine synthase, vitamin B-12 accepts a methyl group from 5,methyl-
tetrahydrofolate, which returns to tetrahydrofolate (THF). This process converts 
cobalamin to methyl-cobalamin, which in turn, donates its methyl-group to homocysteine 
to form methionine, thus regenerating cobalamin to continue the folate cycle. With 
vitamin B-12 deficiency, methyl-THF is not reconverted back to THF, causing a 
breakdown in the cycle, and reduction of the generation of methylene-THF, necessary for 
DNA synthesis. 
 Additionally, cobalamin functions as a coenzyme in the conversion of 
methylmalonyl-CoA to succinyl-CoA, which can enter the Kreb’s Cycle to produce 
energy.  During B-12 deficiency levels methylmalonyl-CoA increase, as it is unable to be 
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converted to succinyl-CoA. Methylmanoyl-CoA spontaneously converts to 
methylmalonic acid, a functional measure of vitamin B-12 status. The aforementioned 
cycles do not function properly without adequate folate or vitamin B-12, diminishing the 
ability to replicate DNA efficiently. This becomes evident with macrocytic anemia, as red 
blood cells do not have enough genetic material to divide properly, and therefore appear 
enlarged. Data suggest that an overabundance of folate, in the form of folic acid from 
fortified foods, may result in a bypass of multi-step, B-12 dependent folate cycle in favor 
of converting the reduced folic acid from our diet into the necessary 5,10,methyl-
tetrahydrofolate, thus preventing the onset of macrocytic anemia.7,8
	  
Figure	  1	  Folate,	  B-­12	  cycle1 	  	  	  
 Although successful in reducing NTD, higher consumption of folic acid due to 
fortification may result in delayed diagnosis of B-12 deficiency as indicated by 
randomized control studies in animals, and human case and cohort studies.9,7 Numerous 
1	  Folate,	  vitamin	  B-­‐12	  and	  methyl-­‐group	  transfer	  cycle.	  	  AdB12	  ,	  adenosyl	  cobalamin;	  FAD,	  flavin	  adenine	  dinucleotide;	  FIGLU,	  formiminoglutamic	  acid;	  MMA,	  methylmalonic	  acid;	  PLP,	  pyridoxal	  phosphate;	  SAH,	  s-­‐adnosyl	  homocysteine;	  SAM,	  s-­‐adnosyl	  methionine;	  THF,	  tetrahydrofolate.	  Adapted	  from	  Selhub	  et	  al	  (2008).	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case studies have shown an increase of neurological complications due to undiagnosed B-
12 deficiency.5 Therefore, increased folic acid consumption may amplify the risk of 
developing potentially irreversible neuropathology as a result of undiagnosed vitamin B-
12 deficiency.5–7 
Significance 
Previous studies have shown a relationship between elevated serum folate and the 
prevalence of B-12 deficiency.7,10–12 However, the literature is mixed as to the masking 
effect of folic acid. Clarke et al (2008) examined vitamin B-12 status in the United 
Kingdom, where folic acid fortification is voluntary, not mandatory; the sample 
population were elderly, and although this population is at higher risk for vitamin B-12 
deficiency, it is not representative of the general population.13 Mills et al (2011) found no 
evidence suggesting vitamin B-12 masking has occurred in Trinity College students in 
Dublin, Ireland.14 Additionally, a baseline investigation of serum folate in Australia 
found that Aboriginals tend to be folate deficient, yet are B-12 replete, in large part due to 
minimal consumption of baked flour goods.15  
 Both Vitamin B-12 deficiency and folic acid deficiency are directly linked to the 
onset of macrocytosis. As folic acid consumption increases through fortification of 
cereals and processed grain products, the folate-trap that occurs during vitamin B-12 
deficiency is no longer relevant. The excess folic acid from fortification is converted to 
THF and enters the folate cycle to generate the raw materials for DNA synthesis, thus 
preventing the onset of macrocytosis. Without this clinical manifestation, B-12 deficiency 
can go undiagnosed until neurological damage occurs. Thus, it seems that folic acid 
fortification may play a role in masking the clinical diagnosis of vitamin B-12 deficiency. 
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This may be especially true in those already at risk for vitamin B-12 deficiency, including 
the elderly, vegetarians, vegans, and pregnant women.5,16 
Objectives 
 A comparison of pre- and post-fortification prevalence of hypovitamin-B-12 without 
macrocytosis has never performed using population-wide data. Therefore the objective of 
this study was to investigate if the proportion of those with vitamin B-12 deficiency, 
presenting without macrocytosis, has significantly increased in the post folic acid 
fortification period (after January 1, 1998) compared to the pre-fortification period using 
data from the National Health and Nutrition Examination Survey (NHANES), a 
nationally representative sample survey. 
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CHAPTER II 
REVIEW OF LITERATURE 
 
The reduction of NTDs was the impetus behind folic acid fortification programs 
across the world. These programs have been heralded as public health success stories due 
to the significant reduction of neural tube defects. However, the positive impact of these 
programs has since been met with controversy:  unintended consequences, including the 
masking of vitamin B-12 deficiency. 
Impact of folic acid fortification on the prevalence of NTDs 
 Honein et al (2001) performed one of the first post-fortification period analyses 
on the impact of the folic acid fortification program with the prevalence of neural tube 
defects in the United States.4The study included birth certificate reporting of spina bifida 
or anencephaly from 40 states from January 1990 through December 1999. A pre-
fortification population from 1990-1996 was used as a baseline measure of the prevalence 
of NTD.  However, a more specific time-dependent group from five quarters immediately 
before and five quarters immediately following fortification were used for direct 
comparisons. Prevalence of spina bifida reported from October 1995 through December 
1996, representative of the pre-fortification period, was 26.2 per 100,000 live births. 
During the post fortification period observed, the prevalence of spina bifida decreased to 
20.2 per 100,000 live births, a reduction of 23% (PR, 0.77; 95% CI: 0.70, 0.84). 
Prevalence for anencephaly was 11.6 per 100,000 live births in the pre-fortification
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period and dropped to 10.3 per 100,000 live births, representing an 11% decline (PR, 
0.89; 95% CI: 0.78, 1.01). Total NTDs saw a 19% reduction (PR, 0.81; 95% CI: 0.75, 
0.87) in prevalence in the post-fortification period observed in this study. A relatively 
consistent, long-term downward trend in the prevalence of anencephaly was seen prior to 
the mandatory fortification in 1998, however, the authors cautioned about a direct 
attribution of folic acid fortification with the decrease in anencephaly during the post-
fortification period. This study only included live births, and it did not account for 
spontaneous or induced abortions, which might have caused an underreporting of true 
incidence and prevalence for NTD. 
Boulet et al (2008) analyzed data from the National Birth Defects Prevention 
Network NTD Ascertainment Project from 1999-2004 in order to establish a trend in 
NTD during the post-fortification period.1A total of 3,311 cases of spina bifida and 2,116 
cases of anencephaly were reported. A significant decrease of 10% (PR, 0.90; 95% CI, 
0.84-0.96) was seen for the combination of spina bifida and anencephaly from 1999-2000 
and 2003-2004. However, when taken alone, the decline in spina bifida was found to be 
insignificant (PR 0.97; 95% CI: 0.89, 1.05), whereas the decline in anencephaly was 
significant (PR 0.80; 95% CI: 0.72, 0.89). The authors postulated that the prevalence rate 
of spina bifida might plateau at these lower levels as serum folate levels have improved, 
approaching the limit of folic-acid-preventable defects.  
Interestingly, Mosley et al (2008) were unable to correlate folic acid 
supplementation or dietary folate intake with NTD after analyzing data from the National 
Birth Defects Prevention Study from 1998-2003, a case-control study.18Cases that 
reported not using supplements did not differ from non-supplement using controls with 
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consumption of dietary folate. Additionally, similar results were found for women who 
used supplements between 3 months prior to pregnancy through the first month of 
pregnancy compared to those who initiated supplement use after the first month of 
pregnancy. The authors postulate that the sample population may have had sufficient 
folate status as to be protective against folate-dependent neural tube defects, and cases 
could be the result of other factors beyond folate consumption. Although supplementation 
use and dietary folate did not correlate, significant differences between cases and controls 
existed for race-ethnicity, education, and income. Cases were more likely to be Hispanic, 
less likely to report education beyond high school, and less likely to report income at or 
beyond $50,000. Anencephaly taken alone was associated with a higher likelihood of 
reporting smoking or alcohol use during pregnancy when compared to controls. For spina 
bifida alone, cases were more likely to have a BMI ≥30kg/m2 and less likely to report the 
pregnancy as intended than controls.  
Thompson et al (2009) assessed the literature on NTD in Canada with regards to 
serum folate and vitamin B-12 status.2Folic acid fortification was found to have a marked 
reduction on the prevalence of NTD in Ontario based on the analysis of 336,963 women 
between the pre- and post-fortification periods. The prevalence dropped from 
113/100,000 pregnancies during the pre-fortification period to 58/100,000 pregnancies 
post-fortification (PR 0.52; 95% CI, 0.40, 11.0). For vitamin B-12 status in the lowest 
quartile, as measured by holotranscobalamin, the odds ratio of a NTD was 3.2 (95% CI: 
0.94, 11.0) and the population attributable risk was as high as 35%. This indicates that 
low vitamin B-12 status may play a role in NTD prevalence. Data suggest that as many as 
5% of women of childbearing age in Ontario have low vitamin B-12 status. The authors 
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suggested the development of a randomized controlled trail to investigate the impact of 
low vitamin B-12 status on the development of NTDs. 
In their review, Obican et al (2010) looked at the literature surrounding our 
understanding of genetic impacts on enzyme function in the folate pathway as well as 
epidemiologic investigations into the role of folic acid embryonic development.1Most 
notably within the genetic sphere of folate metabolism is the impact folate-binding 
protein 1 (Folr1) plays on embryonic development. Data suggest that this membrane-
bound receptor is expressed more on neural crest and neuroeptithelial cells during 
development, and therefore it plays a significant role in the link between folate and NTD. 
Knocking out this gene in mice resulted in severe developmental abnormalities, often 
leading to spontaneous abortion. However, when supplemented with folic acid, 
spontaneous abortions were reduced, but malformations persisted, including those in the 
formations of the neural tube, cardiovascular system, and lip and palate structures. 
Additionally the role of Pcft/Hcp1, a transporter found in the intestines and involved with 
both heme and folate absorption, was strongly associated with the development of 
macrocytic anemia once knocked out in mice. Methyl-tetrahydrofolate reductase 
polymorphisms were shown to be a genetic risk factor for NTD. As for fortification 
programs, the review found a worldwide reduction of 46% (95% CI: 0.37, 0.54) in the 
prevalence of NTD as a result of fortification programs. In the United States, an overall 
reduction in NTD of 19% has been observed. As a result, these programs have been 
deemed a public health success, despite potential adverse effects related to vitamin B-12 
deficiency masking, and the increase of colorectal cancer incidence by an absolute 
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incidence of 4-6 cases/100,000 individuals during the immediate post-fortification 
years.19 
Measuring vitamin B-12 and folate status 
Lack of consensus in the definition vitamin B-12 deficiency has been the most 
difficult aspect in the investigation into the potential masking effect posed by increased 
folic acid consumption as a result of grain fortification. No gold standard yet exists for 
the measurement and definition of vitamin B-12 deficiency, and various levels for serum 
B-12 concentrations are used throughout the literature as the cut point to indicate 
deficiency. The range for serum B-12 concentration cut off points fall as low as 74 
pmol/L to as high as 258 pmol/L. Measuring indirect functional indicators versus direct 
serum concentrations can also be problematic as age, gender, and medical conditions can 
alter these values and hamper diagnosis of vitamin B-12 deficiency.  
In 2008 Selhub et al set out to establish consensus with regards to direct 
measurement of plasma or red blood cell concentrations of folate and vitamin B-12, 
versus the measurement of functional indicators such as mean corpuscular volume 
(MCV), serum methylmalonic acid (MMA), and serum homocysteine.16However, the 
authors noted the difficulty in establishing a standard as both direct concentrations and 
functional indicator concentrations change with age and gender. Serum folate levels are 
nearly twice as high for those older than 60 years versus those aged 12-19 years. A 
similar trend exists for red blood cell folate. The opposite is true for serum vitamin B-12 
concentrations: a decrease in concentration is seen with an increase in age. Establishing 
an optimal plasma folate, serum B-12 or red blood cell folate concentration that is 
applicable for everyone is almost impossible because of fluctuations that occur across the 
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age spectrum and differences attributable to gender. The use of these direct measures may 
not be indicative of a true vitamin deficiency. Functional indicators for folic acid are a 
combination of homocysteine and methylmalonic acid, while the best functional indicator 
for vitamin B-12 is MMA. Since cellular homocysteine homeostasis is tightly controlled, 
excess homocysteine ends up in blood; however, plasma homocysteine increases with 
age, and is found at higher concentrations in men than women. The researchers found a 
biphasic relationship between serum vitamin concentrations and their functional 
indicators, and therefore they constructed two-phase regression models to determine at 
what plasma concentration the functional indicators achieve a minimal optimal level. 
Serum folate concentrations around 10 nmol/L achieved optimal homocysteine 
concentrations as indicated by the flattening of the biphasic curve. Red blood cell folate 
concentration of 340 nmol/L produced the optimal level of homocysteine. For serum 
vitamin B-12, a concentration of 150 pmol/L established the minimal optimal level of 
MMA, however a concentration of 300 pmol/L was found for homocysteine. Based on 
data the from the regression analysis, a cut point of serum vitamin B-12 concentration of 
150 pmol/L is in accordance with other clinical findings; however the authors suggest the 
use of 300 pmol/L for portions of the population, like the elderly, where vitamin B-12 
deficiency occurs at a higher rate.  
Ray et al (2000) performed analysis on data obtained from MDS Laboratories of 
Ontario on individuals who had serum homocysteine, RBC folate, and serum vitamin B-
12 measures taken over an nine month period of time in 1999.10The data from a total of 
692 individuals met the criteria for inclusion for analysis. A concentration of <120 
pmol/L was set as low vitamin B-12 status, and between 120-150 pmol/L as 
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indeterminate vitamin B-12 status. The geometric mean levels for serum and RBC folate, 
as well as serum vitamin B-12, were higher for females compared to males in this 
population. A geometric mean of serum homocysteine was significantly higher in males 
(9.3 µmol/L) than in women (8.3µmol/L). Elevated homocysteine ( >15 µmol/L) was 
found to be a poor indicator of vitamin B-12 deficiency as the probability of having 
serum vitamin B-12 concentration <120 pmol/L in the presence of elevated homocysteine 
levels was 7.4%. Thus the authors advise the use of caution when using homocysteine 
levels as a sole indicator of vitamin B-12 deficiency. 
Folate and B-12 status in countries with mandatory fortification  
Ray et al (2008) performed a retrospective cross-sectional study to determine 
prevalence of vitamin B-12 deficiency in Canadian women of reproductive age.20This 
study took place nearly a decade after Canada mandated folic acid fortification. Serum 
vitamin B-12 concentrations below 125 pmol/L were set as indicating vitamin B-12 
deficiency. A significant difference in mean serum vitamin B-12 concentration was 
associated with stage of pregnancy (≤28 days, indicating neural tube closure had yet to 
occur; and >28 days, suggestive of neural tube closure). Vitamin B-12 deficiency 
occurred in 6.9% of non-pregnant women, 5.2% of women pregnant ≤28 days, and 10.1% 
of women pregnant >28 days. This last group of women was found to be 40% (95% CI: 
10-80) more likely to be deficient in vitamin B-12 than non-pregnant women. 
Ganji and Kafai (2012) conducted an epidemiological investigation into the 
prevalence and attributable risk of elevated serum MMA, a sensitive functional measure 
of vitamin B-12 status, in the post-fortification period.12Using data from three cycles of 
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NHANES (1999-2004), a final sample size of 18,238 was obtained. Elevated MMA was 
defined as >350 nmol/L. Serum creatinine was used as a determinant for kidney function 
and set at ≥130 µmol/L to indicate kidney dysfunction. Serum vitamin B-12 
concentrations <148 pmol/L was used to establish vitamin B-12 deficiency. For this 
sample population, age, race-ethnicity, supplement use, and serum vitamin B-12 
concentration were linked to elevated MMA. The likelihood of having elevated MMA 
was found to be significantly higher in those with serum vitamin B-12 concentrations 
<148 pmol/L (PR, 27.6%; OR, 13.5; P < 0.0001), as well as in those who were ≥60 years 
of age (PR, 8.3%; OR, 4.0; P < 0.0001), and in non-supplement users (PR, 3.1%; OR, 
1.93; P <0.0001). The population attributable risk percentage for elevated serum MMA 
was strongly associated with age at nearly 41% for those aged 60 and older versus those 
aged less than 60 years; with non-Hispanic white race-ethnicity at nearly 25% compared 
to all other ethnicities combined; and with those who had serum vitamin B-12 <148 
pmol/L at roughly 16%. Factors that increase the likelihood of having elevated serum 
MMA include being non-Hispanic white, being older than 60, having low vitamin B-12 
status, and not using supplements. The prevalence of low vitamin B-12 status was 2.0%. 
Overall, an estimated reduction of about 5 cases of elevated serum MMA per 1000 
people would be eliminated if vitamin B-12 status increased to ≥148 pmol/L. 
Australia introduced mandatory folic acid fortification for wheat flour in 2009, 
but the country has had a voluntary fortification policy established since 1995. Maxwell 
et all (2012) set out to establish the baseline of folate status in aboriginal and non-
aboriginal Western Australians immediately prior to mandatory fortification.15The 
participants included 191 Aboriginal and 159 non-aboriginal Australians. The cutoff for 
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folate deficiency was set at <250 ng/mL for the assay used, which equates to 140 ng/mL 
used by the BioRad assay kit used by NHANES. The cutoff for vitamin B-12 deficiency 
was set at 200 pg/mL. The majority of participants reported not using vitamin 
supplements. All participants were found to be vitamin B-12 replete. Furthermore, 10% 
of aboriginal women (95% CI; 5, 19), and 26% of aboriginal men (95% CI; 2, 12) had 
RBC folate levels below 250 ng/mL, while no non-aboriginal women (95% CI; 0, 4) and 
only 4% of non-aboriginal men (95% CI; 2, 12) fell below 250 ng/mL for RBC folate. 
The higher rate of suboptimal folate status in aboriginal women is in line with other 
studies that found increased prevalence of NTDs in the aboriginal population compared 
to the non-aboriginal population.  
Post-fortification era evidence for vitamin B-12 masking 
Mills et al (2003) analyzed data from 1,573 patients at the Veteran’s Affairs 
Medical Center in Washington, DC between 1992 and 2000 to determine whether folic 
acid fortification increased the proportion of those with low vitamin B-12 status (defined 
as <258 pmol/L) without macrocytic anemia.21There were 1573 subjects who had both 
serum B-12 and MCV measured: 96.1% were male, 69% were African American, and the 
median age was 67 years. The proportion of those with low vitamin B-12 status without 
megaloblastic anemia (defined as MCV >96.7 fL) for the pre fortification period was 
39.2%. For the peri-fortification and post-fortification periods the proportions were 
45.5% and 37.6%, respectively. There was no statistically significant change in 
proportions of low serum vitamin B-12 without anemia from the pre- to the post-
fortification period (OR 0.95; 95% CI; 0.74, 1.22; P = 0.67). When the limit for low 
vitamin B-12 was adjusted downward to <150 pmol/L, no significant difference between 
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pre and post-fortification periods was found for those with low vitamin B-12 status 
without megaloblastic anemia. However, nearly 60% of cases with initial low vitamin B-
12 status presented with macrocytosis. Interestingly, the data suggest the likelihood of 
low vitamin B-12 status is greater in those <60 years of age than for those greater than 60 
years (P < 0.0001, logistical regression). 
Pfeiffer et al (2005) reviewed NHANES III and NHANES 1999-2000 data to 
establish the effect of folic acid fortification on biochemical indicators of B-12 status 
including serum B-12, MMA, serum homocysteine, serum folate, and red blood cell 
folate.8They note that low serum folate in conjunction with low vitamin B-12 status and 
an elevated homocysteine level is associated with the development and progression of 
dementia and Alzheimer’s disease, as well as other conditions of cognitive dysfunction: 
declined psychical functioning; psychiatric disorders; and increased risk of carotid artery 
stenosis. In their analysis they found a significant upward shift in serum folate across the 
population, a moderate increase in RBC folate, and a slight increase in serum vitamin B-
12. Prevalence of low serum folate (set at <6.8 nmol/L) decreased by 16%; low RBC 
folate (<317 nmol/mL) decreased by 31%; and vitamin B-12 deficiency (set at <74 
pmol/L) “moderately low serum B-12” (<185 pmol/L) remained unchanged at 1% and 
5% respectively, Since initiation of fortification in the United States, a shift to higher 
serum folate concentrations has occurred.. This trend is higher than the expected range of 
70-140 µg/d of folate as anticipated by the US fortification program. Based on the cutoff 
values established in this study, <1% had serum vitamin B-12 concentrations met the 
definition of deficiency, whereas 5% of the sample had vitamin B-12 levels below 148 
pmol/L, indicating moderately low vitamin B-12 status. Additionally, the prevalence of 
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moderately low serum vitamin B-12 concentration decreased from the pre-fortification 
period to the post-fortification period in the elderly population. The authors noted the 
lack of evidence, suggesting an increased risk of B-12 masking. However, due to the 
limited passage of time between pre-fortification and post-fortification measurements 
presented in this study, they suggested inclusion of additional NHANES survey periods 
in the analysis to establish if the trend of vitamin B-12 masking exists. 
Clarke et al (2008) investigated the relationship of high serum folate and low B-
12 status with cognitive impairment and anemia in 2,476 elderly persons in the United 
Kingdom (UK).13Subjects included two cohorts: one from before and one from after 
voluntary folic acid fortification.  Low vitamin B-12 status was established for this study 
at concentrations of holotranscobalamin (holoTC) <45 pmol/L. Serum folate >30 nmol/L 
was considered a high level of concentration. Anemia was defined as hemoglobin <12 
g/dL in men, and <11 g/dL in women. Total serum folate levels increased between the 
two groups measurements; however, B-12 levels remained fairly constant. An increased 
risk of anemia was observed amongst those in the lowest tertile for both serum folate (OR 
2.02; 95% CI; 1.46, 2.80) and holoTC concentrations (OR 1.87; 95% CI; 1.44, 2.43), 
respectively, as compared to those in the upper tertile of each biochemical marker. 
Additionally, increased risk of cognitive impairment was seen in the lowest tertiles for 
folate (OR 1.55; 95% CI; 1.35, 2.12) compared to the upper tertile, and for the lowest 
tertile of serum vitamin B-12 (OR 1.87; 95% CI; 1.44, 2.43) compared to the upper tertile 
for vitamin B-12. There was no significant difference in mean homocysteine or MMA 
concentrations in those with low vitamin B-12 status when stratified by normal and high 
serum folate levels. Additionally, no significant difference in the risk of cognitive 
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impairment was found in those with low serum vitamin B-12 and normal serum folate 
(OR 1.5; 95% CI; 0.91, 2.56) versus elevates serum folate (OR 1.45; 95% CI 1.19, 1.76). 
No difference in risk of anemia was found between those with low vitamin B-12 status 
and normal serum folate versus high serum folate concentrations. These analyses indicate 
that an increased level of serum folate in conjunction with low vitamin B-12 status does 
not increase the risk of cognitive impairment in elderly UK citizens. The authors 
speculate that the increase in serum folate in the UK has occurred more recently 
compared to the United States; therefore additional time may need to elapse to show the 
true relationship between elevated serum folate and low vitamin B-12 status, and 
cognitive impairment.  
Mills et al (2011) investigated the effects of high folate concentrations on vitamin 
B-12 status of 2,507 students attending Trinity College in Dublin, Ireland. Non-fasting 
blood samples were obtained to analyze serum folate, RBC folate, serum vitamin B-12, 
MMA, and plasma homocysteine levels. Methyl-tetrahydrofolate reductase (MTHFR) 
genotyping was also performed. Anemia was defined <13.0 g/dL in men and <12.0 g/dL 
in women. Macrocytosis was defined as an MCV ≥99 fL. Serum holoTC were deemed 
low if <20 pmol/L. Elevated homocysteine was set at >15 µmol/L; elevated serum MMA 
concentration was defined as >0.26 µmol/L; elevated serum folate was >30 nmol/L; and 
low serum vitamin B-12 status was set at a cut off of 148 pmol/L. Participants were 
grouped according to serum vitamin B-12 concentration (above or below 148 pmol/L) 
and serum folate status (above or below 30 nmol/L).  Group 1 (n=43) consisted of those 
with low vitamin B-12 status and elevated serum folate, and Group 2 (n=85) consisted of 
those with low vitamin B-12 status and normal folate status. As expected those that tested 
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positive for the MTHFR gene variant had significantly lower serum and RBC folate (P < 
0.001) and higher concentrations of homocysteine (P < 0.001). After adjusting for 
confounds for age, sex, serum ferritin, and plasma creatinine, MTHFR was not a 
significant predictor of anemia (OR 0.483; 95% CI; 0.130, 1.946; P = 0.3).  No subjects 
in either group displayed macrocytosis. No participants in Group 1 had both elevated 
homocysteine and MMA levels, whereas nine participants in Group 2 did (10.6%).  The 
results of this study do not support the claim that elevated serum folate interferes with 
vitamin B-12 metabolism in those who are vitamin B-12 deficient.  
Hirsch et al (2002) designed a prospective study to investigate the immediate 
impact of mandatory folic acid fortification on an elderly population in Chile. Based on 
the evidence of folic acid’s impact of reducing the prevalence of neural tube defects, 
Chile mandated folic acid fortification starting in 2000.11A total of 108 participants 
agreed to the study. The subjects had fasting blood samples taken in December 1999, 
before the mandatory fortification, and again in July 2000, after the mandate had taken 
effect. Both serum folate and serum vitamin B-12 levels were positively skewed at 
baseline, whereas homocysteine was normally distributed. Serum folate levels increased 
from the pre- to post-fortification periods from 16.2 nmol/L to 32.7 nmol/L (P < 0.001). 
Serum homocysteine levels were reduced by 11.7% in the post-fortification period from 
12.95 nmol/L to 11.43 µmol/L (P < 0.001). Nearly one-third of participants had 
“subclinical” vitamin B-12 deficiency (defined as serum vitamin B-12 <165 pol/L) at 
baseline with no improvement at the second measurement. The authors concluded that 
with prolonged vitamin B-12 deficiencies and improved folate status a masking effect 
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could occur in the future. Therefore, the authors stated that fortification of grains with 
folic acid might not be suitable for an elderly population. 
In their critical review Selhub and Paul (2011) indicated that folic acid 
consumption increased to more than 200 µg, well above the predicted 140 µg increase 
estimated by the Food and Drug Administration (FDA).22 Additionally a larger 
percentage of the population, as determined by analysis done on the Framingham cohort, 
consumed more than the FDA’s Upper Limit recommendation of 1000 µg per day, 
calculated by the lowest observed adverse effect level multiplied by a factor of five. In 
NHANES data analysis, those with low vitamin B-12 status and serum folate levels >59 
nmol/L were observed to have a nearly two-fold increase in prevalence of anemia and 
cognitive impairment. Un-metabolized folic acid present in the blood is associated with 
diminished cognitive test scores in seniors with low serum vitamin B-12 levels. The 
authors argue that these findings suggest high serum folate levels exacerbate both 
biochemical and clinical statuses for those with vitamin B-12 deficiency. 
Morris et al (2007) analyzed NHANES data from two cycles (1999-2000, 2001-
2002) of the survey for the effect of folic acid fortification in relation to anemia, 
macrocytosis, and cognitive impairment in older Americans.9 Cut off levels were set for 
anemia at <12 g/dL for women and <13 g/dL for men and in accordance with the World 
Health Organization criteria; MCV ≥99 fL; low serum vitamin B-12 at 148 pmol/L; 
elevated serum MMA >210 nmol/L; and high folate status as >59 nmol/L. Excluded were 
those with elevated serum creatinine levels (>131 µmol/L for men and >115 µmol/L for 
women) as indicative of renal dysfunction; recent anemia therapy; history of stroke; 
heavy alcohol use; and kidney, liver, or coronary artery diseases. Seniors with low 
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vitamin B-12 status in conjunction with elevated serum folate levels represented 
approximately 4% of the sample of 1,684 eligible participants. Among those with normal 
vitamin B-12 status, high serum folate concentrations had a protective effect for cognitive 
impairment.  Low vitamin B-12 status regardless of folate concentration was associated 
with increased prevalence of anemia and cognitive impairment. However, the strongest 
association for increased cognitive impairment was see in those classified as low vitamin 
B-12 status with high serum folate concentration (OR: 2.6; 95% CI: 1.1, 6.1). Anemia 
was observed nearly a five times more often in those with low vitamin B-12 and high 
serum folate levels as compared to those in normal vitamin B-12 and folate groups. 
Elevate homocysteine levels were significantly lower in the group with low vitamin B-12 
status and normal folate concentrations versus elevated folate concentrations. This study 
found that high levels of serum folate provided a protective effect against cognitive 
impairment for vitamin B-12 replete older individuals, but in individuals with low 
vitamin B-12 status, elevated serum folate advanced the onset or progression of cognitive 
impairment in line with the neurological manifestations associated with vitamin B-12 
deficiency. 
Wyckoff and Ganji (2007) investigated the change in proportion of what? those 
with low serum vitamin B-12 (defined as <258 pmol/L) without macrocytosis (defined as 
MCV >96.7 fL).7 Medical records at Rush University Medical Center from individuals 
≥19 years of age who had serum vitamin B-12 and MCV measured between January 
1995 and December 2005 were examined. Since the span of time incorporated the folic 
acid fortification date in 1998, pre and post-fortification data could be compared. A total 
of 633 records were identified that met the inclusion criteria, and subjects were stratified 
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into three groups: pre-fortification, peri-fortification, and post fortification. After 
analysis, MCV was found to be significantly lower in the post-fortification period 
compared to the pre-and peri-fortification periods for gender (P<0.001) and race-ethnicity 
(P < 0.001). Of those with low vitamin B-12 concentration, the proportion of those 
without macrocytosis increased in each stratified group: 70%, 85%, and 87% 
respectively, and each were significantly different (P  < 0.001). During the post 
fortification period, the odds ratio for low vitamin B-12 status without macrocytosis, 
when adjusted for age, gender, and race, was three-times greater for the post-fortification 
period, compared those in the pre-fortification period. This suggests that an increase in 
the proportion of those with low serum B-12 without macrocytosis in the post-
fortification era. 
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CHAPTER III 
METHODS 
Data Acquisition  
Data from NHANES III, during the pre-fortification period, and three surveys 
from the post-fortification period, NAHNES 1999-2000, NHANES 2001-2002, and 
NHANES 2003-2004 and NHANES 2005-2006, were used to determine if the prevalence 
of B-12 deficiency without hematological manifestations has increased during the post-
fortification period. This data is from publically available databases, maintained and 
released by the National Center of Health Statistics (NCHS), and a detailed description of 
each survey’s methodologies and analytic guidelines were reported elsewhere, but a brief 
description of each survey follows.23,24 The NHANES III, a periodic survey conducted 
between October 1988 and October 1994, and using a complex, multi-staged, stratified, 
clustered sample,  consisted of 36,995 participants. Of those, 33,994 individuals were 
interviewed in their home. A total of 30,818 participants were examined by trained 
medical professionals in Mobile Examination Centers (MEC) and an additional 493 had 
examinations performed in their home.  After the NHANES III, data collection switched 
to annual surveys. This study included four cycles of the continuous annual NHANES 
series (1999-2000, 2001-2002, 2003-2004, and 2005-2006). The NHANES 1999-2000 
was conducted between March 1999 and December 2000, and included 9,965 individuals, 
all interviewed in-home, and 9,282 examined in MECs; NHANES 2001-2002, conducted 
between January 2001 and December 2002, was comprised of 11,093 individuals, all
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interviews conducted in-home, and 10,477 examined in MECs; NHANES 2003-2004, 
conducted between January 2003 and December 2004, was comprised of 12,761 
individuals, 10,122 interviewed in-home, 9,643 examined in MEC. The NHANES 2005-
2006 was conducted between January 2005 and December 2006, and consisted of 12,862 
individuals. A total of 10,348 were interviewed in-home, and 9,950 were examined in 
MECs. Taken together, the continuous NHANES combined sample population was 
57,158, and 39,352 medically examined individuals. All blood samples were taken with 
consent, by venipuncture following standard protocol either during the home 
examination, or in the MEC.  The NHANES 1999-2005 surveys a quantitative, 
automated hematology analyzer was used to measure MCV (Coulter method), serum B-
12 and serum folate were measured by using the Bio-Rad Laboratories "Quantaphase II 
Folate/vitamin B12" radioassay kit. NHANES III utilized a previous generation kit, the 
Bio-Rad Laboratories “Quantaphase Folate” radioassay kit. 
Variable Selection 
 This study focuses on the masking effect of folic acid fortification on low vitamin 
B-12 status as evidenced by low serum B-12 and without macrocytic anemia. The serum 
concentrations of primary concern in this investigation were serum folate, serum vitamin 
B-12, and MCV. The standard definition of macrocytosis is a MCV >98 fL for both men 
and women. Although no standard has been established for a specific concentration of B-
12 that signifies deficiency, a concentrations <148 pmol/L was considered to be deficient 
in accord with other studies, and the roundtable for B-12 biomarkers in NHANES.8,25,26 
These data were collected during the medical examination portions of each NHANES 
data collection period. 
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 Demographics of interest and assessed for significance were race/ethnicity, age, 
gender, education, and PIR. Additional covariates analyzed were alcohol consumption, 
smoking status, and serum creatinine. Excessive alcohol intake can result in an increase 
in MCV through interference with folate metabolism.27 Elevated serum creatinine is an 
indicator of kidney dysfunction, which can result in the development of anemia. This 
occurs due to decreased ability of the kidneys to synthesize erythropoietin, the red blood 
cell production stimulation hormone.6 Smoking as been linked to disruptions in the B-12 
metabolic pathway, primarily in the form of elevated homocysteine levels.28 These data 
were collected during the examination and questionnaire portion of the study, except for 
creatinine, which was collected during the medical examination. From the analysis of the 
NHANES data, individuals with missing data for any variable were excluded from 
analysis.  
Recoding Data 
Data from NHANES III and the Continuous NHANES series have different 
variable names, and different reporting formats. Therefore data had to be cleaned and 
reformatted in order to be comparable. Demographic data from the continuous NHANES 
set for race/ethnicity, and education were recoded to reflect the data from NHANES III. 
The upper cutoff value for reporting age shifted down from NHANES III to the 
continuous NHANES series, from 90 years to 85 years. This resulted in recoding any age 
>85 in the NHANES III set to equal 85. Education reporting varied from each era, and 
was recoded as categorical data representing those who did not graduate high school, 
those identifying as only a high school graduate and, lastly, those who identified as being 
a college graduate. PIR was reported differently in both versions of NHANES and 
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required recoding. The upper cutoff value for PIR in the continuous NHANES was set at 
five, where NHANES III calculated the precise ratio. Thus, the data from NHANES III 
were recoded so that any data point for PIR >5 would be equal to five, in accordance with 
the reporting system of the continuous NAHNES.  Alcohol consumption was tallied from 
the self-reported average number of alcoholic drinks per day and recoded as an average 
daily intake of less than or equal to one drink, two to three drinks, and greater than three 
drinks. Smoking was recoded a dichotomous categorical variable, ‘yes’ or ‘no,’ based on 
current smoking status. Those that reported as “smoke sometimes” in the continuous 
NHANES series were considered as smokers.  
A new variable was created using the data for MCV and serum B-12 
concentrations to establish a marker for the masking effect. Those individuals who met 
the criteria for low serum B-12 (<148 pmol/L) in addition to normal MCV levels (<98 
fL) were flagged as “masking effect present” for the purpose of this study. All other 
individuals who did not meet these two criteria were flagged as “no masking effect 
present.” Lastly, a new variable was assigned to each data set establishing from which 
period the data originated. This “pre/post” variable was created and assigned prior to the 
merging of NAHNES III and continuous NHANES data sets, where a value of zero 
represented the pre-fortification data, and a value of one represented the post-fortification 
data. Once all variables were properly coded, and new variables assigned, the separate 
data sets were merged into one for final analysis. Additional variables were created from 
stratifying age into four groups: ≤19 years, 20-39 years, 40-59 years, and >60 years old. 
A new variable for PIR was stratified into categories based on the quartiles for the 
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continuous variable. The four categories represented quartile ranges for PIR from ≤1.99, 
1.2-2.37, 2.38-4.21 and >4.22. 
Statistical Analysis 
 Univariate analysis was conducted for each independent variable in order 
to determine if any were significant predictors of serum B-12 status, and the distribution 
of each variable. A non-parametric two-sample test was performed to establish 
differences between the distributions of each variable for pre and post-fortification 
groups. The Kolmogorov-Smirnov two-sample test (D) was used to determine differences 
between the pre- and post-fortification groups for the continuous data. This test was 
chosen as it is robust to outliers and is more sensitive to the change in shape and 
distribution than the Mann-Whitney test. Any variables that were significant at α=0.05 
were then combined to test a full model of B-12 masking. Finally a logistic regression 
was performed in order to establish the likelihood of the masking effect occurring in the 
post-fortification era. These data were analyzed using SAS 9.2 statistical software (SAS 
Institute Inc, Cary, North Carolina.) 	  
	  
	  
	  
	  
	  	   27	  
	  
	  
CHAPTER IV 
RESULTS After	  scrubbing	  for	  missing	  data	  for	  demographics	  (age,	  gender,	  race/ethnicity,	  and	  education),	  serum	  concentrations	  (folate,	  creatinine,	  B-­‐12)	  and	  additional	  confounders	  (PIR,	  smoking	  status,	  and	  alcohol	  consumption)	  over	  90%	  of	  the	  individuals	  from	  the	  combined	  data	  set	  (n=	  76,840)	  were	  removed,	  leaving	  data	  from	  a	  total	  of	  7,242	  individuals	  included	  in	  this	  study.	  The	  process	  for	  selection	  of	  the	  study	  sample	  is	  depicted	  in	  FIGURE	  2.	  The	  population	  was	  comprised	  of	  61%	  males	  (n=4,395)	  and	  39%	  females	  (n=2847),	  who	  were	  an	  average	  age	  of	  45±17.6	  (±SD).	  The	  demographic	  characteristics	  for	  the	  sample	  population	  are	  shown	  in	  
TABLE	  1.	  
Figure	  2	  Sample	  Population	  Funnel	  Selection	  
Total combined NHANES Sample population 
• 83,676 
Total participants examined in MEC 
• 73,346 
Final Sample after exclusion for missing 
data 
• 7242  
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From the pre-fortification group, comprised of the NHANES III sample 
population, data from a total of 1,936 individuals were included in the analysis. The 
majority of this population (62.5%) were males (n=1,210 and the average age of the 
participant was 41 years, with a range of 17-85 years old. Two-thirds of the pre-
fortification era sample population received a high school education or less.  For the PIR, 
the mean was 2.38, and the median was 2.02. Non-Hispanic whites made up the largest 
proportion of individuals at 42% (n=815). Only 35 individuals in the pre-fortification 
period had serum B-12 levels below 148 pmol/L while maintaining normal MCV levels. 
This represents 1.8% of the sample population. The weighted sample of the masking 
effect represents over five hundred thousand individuals, and comprises 2.05% of the 
weighted sample population. 
From the combined NHANES 1999-2006 a total of 5,306 individuals had all 
variable elements required for analysis. This sample was comprised of 60% males 
(n=3,185) and 40% females (n=2,121). The average age of the interviewee was 45 years 
old, a range of 20-85 years.  The proportion of those who graduated college increased in 
the post-fortification period compared to the pre-fortification. When PIR was taken as a 
continuous variable, a significant increase was seen among those in the post-fortification 
period (Kolmogrov-Smirnov D 3.86, P<0.001). The masking effect was present in 129 
individuals in this group, representing 2.43% of the sub-sample population. When the 
sample weight was taken into account, this sample represents nearly 1.5 million 
individuals at 2.32% of the weighted sample population of over 63 million. 
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Table	  1	  Demographics	  by	  fortification	  period	  
Table of Demographics by fortification period 
Fortification Period   
Pre 
n = 1,936 
Post 
n = 5,306 
Total 
n = 7,242 
Gender, n (%) 
Male  1,210 (62.5%) 
 
3,185 (60.03%) 
 
4,395 (60.69%) 
 
Female  726 (37.5%) 
 
2,121 (39.97%) 
 
2,847 (39.31%) 
 
1-19 yrs  47 (2.43%) 
 
0 
 
47 (0.65%) 
 
20-39 yrs  896 (46.28%) 
 
1,915 (36.09%) 
 
2,811 (38.82%) 
 
40-59 yrs  580 (29.96%) 
 
1,783 (33.6%) 
 
2,363 (32.63%) 
 
60+ yrs  413 (21.33%) 
 
1,608 (30.31%) 
 
2,021 (27.91%) 
 
55+	  yrs	   1,423	  (73.50%)	  
 
3,395	  (63.98%)	  
 
4,818	  (66.53%)	  
 
≤55	  yrs	   513	  (26.50%)	  
 
1,911	  (36.02%)	  
 
2,424	  (33.47%)	  
 
Race/Ethnicity, n (%) 
NH white  815 (42.10%) 
 
3,111 (58.63%) 
 
3,926 (54.21%) 
 
NH black 553 (28.56%) 
 
829 (15.62%) 
 
1,382 (19.08%) 
 
Hispanic 509 (26.29%) 
 
1,200 (22.62%) 
 
1,709 (23.60%) 
 
Other 59 (3.05%) 
 
166 (3.13%) 
 
225 (3.11%) 
 
 
Level of Education, n (%) 
< HS 717 (37.04%) 
 
1,473 (27.76%) 
 
2,190 (30.24%) 
 
HS/GED  639 (33.01%) 
 
1,378 (25.97%) 
 
2,017 (27.85%) 
 
College 580 (29.96%) 
 
2,455 (46.27%) 
 
 3,035 (41.91%) 
 
Alcohol     
≤1	  Drink/Day	   334	  (17.25%)	  
 
1,475	  (27.28%)	  
 
1,809	  (24.98%)	  
 
1-­2	  Drinks/Day	   473	  (24.43%)	  
 
1,419	  (26.74%)	  
 
1,892	  (26.13%)	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Table of Demographics by fortification period 
Fortification Period   
Pre 
n = 1,936 
Post 
n = 5,306 
Total 
n = 7,242 
3+	  Drinks/day	   1,129	  (58.32%)	  
 
2,412	  (45.46%)	  
 
3,541	  (48.90%)	  
 
Smoking	  	      
Smoker	   1,105	  (57.08%)	  
 
2,625	  (49.47%)	  
 
3,730	  (52.51%)	  
 
Non-­Smoker	   831	  (42.92%)	  
 
2,681	  (50.53%)	  
 
3,512	  (48.49%)	  
 
Masking Effect1, n (%) 	   	   	  
Present 35	  (1.81%)	  (2.05%)2	  	   129	  (2.43%)	  (2.32%)2	  	   164	  (2.26%)	  (2.24%)2	  	  
Not present 1,901	  (98.19%)	  (97.95%)2	  	   5,177	  (97.57%)	  (97.68%)2	  	   7,078	  (97.74%)	  (97.76%)2	  	  1	  Masking	  effect	  defined	  as	  having	  Serum	  B-­‐12	  <148	  pmol/L	  with	  MCV	  <98	  fL.	  All	  others	  	  that	  did	  not	  meet	  this	  criteria	  were	  defined	  as	  “no	  masking	  effect	  present.”	  2	  Percent	  of	  weighted	  sample.	  
 
The distribution of each variable was analyzed using the Kolmogorov-Smirnov 
(KS) test for normality. This test was chosen over the Shapiro Wilks test because the 
sample size was larger than 2,000. Due to outliers and significant tails, the distributions 
for serum folate, B-12, MCV, and creatinine, as well as age, and PIR were not normally 
distributed as indicated by p-values <0.05 for each variable, and thus required non-
parametric statistical test for analysis. Results from the normality test can be found in 
Appendix A. Due to the skewed distribution of the serum lab values, adjustment was 
required for reporting means. The geometric mean accounts for the effect of extreme 
outliers for the serum lab values. The geometric mean for pre-fortification serum folate 
was 11.68 nmol/L (95% CI, 11.36-12.00); serum B-12 was 335.00 pmol/L (95% CI, 
328.32-341.18); serum creatinine was 1.07 mg/dL (95% CI, 1.06-1.08); and the 
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geometric mean of pre-fortification MCV was 89.62 fL (95% CI, 89.38-89.86). 
Geometric means for serum concentrations in the post-fortification era are as follows: 
folate 26.77 nmol/L (95% CI, 26.40-27.16), B-12 was 334.80 pmol/L (95% CI, 330.63-
339.03), creatinine was 0.84 mg/dL (95% CI, 0.84-0.85), and MCV was 91.07 fL (95% 
CI, 90.92-91.22). 
A significant difference in the distribution of age was seen between the two 
groups, as the average age of the participants increased in the post-fortification period 
(KS D = 0.16, P <0.001). PIR also saw a significant shift in distribution, as it increased in 
the post-fortification group (D = 0.10 P<0.0001). Serum folate levels significantly 
increased in the post-fortification period (D =0.57, P <0.0001), while no significant 
difference was found in the distribution of serum B-12 concentrations between the two 
groups (D =0.02, P< 0.4374). Additionally, a decrease was observed in serum creatinine 
concentration in the post-fortification group, creating a significant difference in the 
distribution of serum creatinine levels (D=0.44 P<0.0001). A shift in MCV was also 
observed, as MVC was significantly different between the pre and post-fortification 
groups (D=0.14, P<0.0001). Education levels also changed significantly (D=0.16, 
P<0.0001) between the two periods, as the proportion of individuals that did not graduate 
high school fell and the proportion of those who graduated college rose in the post-
fortification period. Furthermore, smoking and alcohol consumption both saw significant 
differences in proportions of responses between groups. More individuals reported 
smoking in the post-fortification era (D=0.08, P<0.0001). Alcohol consumption shifted 
down as the proportion of those reporting ≤1 drink/day increased from the pre-
fortification period to the post-fortification period (D=0.13, P<0.001). Lastly, the 
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distribution of those identified with the markers for the masking effect was not 
statistically different between the pre and post-fortification groups (D=0.06, P<0.7139). 
Results for the two-sample tests for each variable can be found in Appendix B. 
Logistic regression analysis was performed using all variables where significant 
differences between pre and post-fortification periods were observed. All covariates were 
combined into a full model as predictors of the masking effect. The global model was 
significant (Wald X2 = 90.49, P<0.0001), with the predictors of masking limited to 
race/ethnicity (Wald X2 = 23.61, P<0.0001) and serum folate concentrations (Wald X2 = 
8.59, P<0.0001). The fortification period trended towards significance (Wald X2 = 2.98, 
P<0.085), as did gender (Wald X2= 3.40 P<0.065). The analysis of effects for the global 
model is in Table 2. 
Table	  2	  Global	  Effect	  for	  the	  Post	  vs.	  Pre-­fortification	  era	  
  Global Analysis of Effects of Post vs. Pre 
Effect DF Wald 
Chi-Square 
Pr > ChiSq 
PREPOST 1 2.9758 0.0845 
 Gender * 1 3.4024 0.0651 
Stratified Age* 3 2.7588 0.4303 
Age 1 0.5630 0.4530 
Race/Ethnicity * 3 23.6102 <.0001 
PIR * 3 4.7567 0.1905 
Serum folate * 1 8.5851 0.0034 
MCV 1 17.2122 <.0001 
Education 2 3.4855 0.1750 
Alcohol 2 0.6321 0.7290 
 *	  Sub-­‐group	  analysis	  indicated	  significant	  risk	  increase	  of	  the	  masking	  effect	  for	  men,	  individuals	  55	  and	  older,	  non-­‐Hispanic	  blacks,	  those	  in	  the	  third	  quartile	  for	  PIR,	  and	  low	  serum	  folate,	  defined	  as	  <6.3	  nmol/L.	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Subgroup analysis was performed for age, gender, race/ethnicity, education, PIR, 
serum folate, alcohol consumption, and smoking across fortification periods. Significant 
findings are reported in TABLE 3. Age was first stratified by twenty-year increments. 
No significant effect was seen with this level of stratification. Age was then stratified into 
those younger than 55 years and those equal to, or older than 55. For those in the post-
fortification period, being older than 55 years of age was a significant predictor of 
displaying low B-12 with no macrocytosis (Wald X2= 3.90 P<0.048) compared to their 
pre-fortification counterparts. This corresponded with more than a 2-fold increase in the 
likelihood of displaying the masking effect in the post-fortification era than the pre-
fortification period for this age group (OR= 2.18, 1.01-4.74). Being less than 55 years old 
was not a significant predictor of the masking effect in the post-fortification period. 
Table	  3	  Significant	  outcomes	  from	  the	  analysis	  of	  effects	  in	  the	  Post-­fortification	  period	  versus	  the	  Pre-­
fortification	  period.	  
Analysis of Effects for Post vs. Pre 
Effect DF Wald 
Chi-Square 
Pr > ChiSq Odds Ratio 95%Wald  
Confidence Limit 
Gender 
Male 1 6.3075 0.0120 2.645 1.238-5.650 
Race/Ethnicity 
NH black 1 4.1069 0.0427 3.115 1.038-9.350 
Stratified Age 
>55 (y) 1 3.9044 0.0482 2.183 1.006-4.737 
Serum Folate2 
 <6.8 nmol/L 1 13.6459 0.0002 35.885 5.371-239.773 
Smoking Status 
Non-smoker 1 11.4197 0.0007 4.631 1.904-11.267 
PIR by Quartile 
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Analysis of Effects for Post vs. Pre 
Effect DF Wald 
Chi-Square 
Pr > ChiSq Odds Ratio 95%Wald  
Confidence Limit 
Q3 1 3.9498 0.0469 3.216 1.016-10.117 
 
 
 
 
Gender had a significant effect in the post-fortification era, as being male proved 
to be a significant predictor of the making effect (Wald X2 = 88.14, P<0.0001). When 
compared to men in the pre-fortification group, men in the post-fortification era had a 
nearly two-fold increase in the likelihood of being B-12 deficient with normal MCV 
(OR= 2.65, 1.24-5.65). No significant effect was found for women (Wald X2 =0.31, 
P<0.5774). Race/ethnicity, specifically being non-Hispanic blacks, had a significant 
effect on being B-12 deficient without macrocytosis in the post-fortification period (Wald 
X2 = 4.12, P<0.0427). Non-Hispanic blacks in the post-fortification era saw a three3-fold 
increase in the odds of displaying the masking effect (OR=3.12, 1.04-9.35) compared to 
their NHANES III counterparts. No other race/ethnicity proved to be a significant 
predictor.  
No significance was observed for the effect of education on the masking effect in 
the pre versus post-fortification groups. Nor was education significant when re-stratified 
to those who did not graduate high school versus those who did across fortification 
periods. Smoking status, however, was significant at predicting of the potential masking. 
Being a non-smoker in the post-fortification era proved to be a significant predictor of the 
masking effect, increasing the odds of displaying the effect nearly 5-fold (OR= 4.63, 
1	  Serum	  folate	  <6.8	  nmol/L	  was	  one	  of	  four	  stratification	  levels.	  When	  re-­‐stratified	  to	  concentrations	  above	  and	  below	  6.8	  nmol/L,	  no	  effect	  was	  seen	  for	  serum	  folate	  and	  masking	  in	  the	  post-­‐fortification	  era.	  
2	  The	  third	  quartile	  for	  PIR	  was	  one	  of	  four	  stratification	  levels.	  When	  re-­‐stratified	  to	  scores	  at	  and	  above	  4.22,	  and	  those	  below,	  no	  effect	  was	  seen	  for	  PIR	  and	  the	  masking	  effect	  in	  the	  post	  fortification	  era.	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1.90-11.27). The act of smoking had no predictive abilities for the masking effect. 
Alcohol consumption had no effect on low B-12 without macrocytosis. 
An effect for PIR was seen when stratified by quartiles. Only the third quartile 
was a significant predictor of the masking effect in the post-fortification period (Wald 
X2= 3.95, P<0.047). For those in the third quartile of PIR, which consisted of a range of 
4.22-4.9, increased likelihood of being B-12 deficient with normal MCV existed in the 
post fortification period compared to those in the pre-fortification period (OR= 3.22, 
1.016-10.177). All other quartiles were not significant predictors of the masking effect in 
the post-fortification period. No significant effect was seen when those at and above a 
PIR of 4.22 were compared to those below 4.22 for the pre and post-fortification time 
periods. When stratified to above, and below or equal to the median (2.38), no significant 
predictive effect was seen for PIR. Additionally, no effect was seen when stratified to 
above or below a PIR of 1.5, or 150% of the poverty line. 
Serum folate was a significant predictor of the masking effect in the global model. 
When stratified using the concentrations established by the World Health Organization 
(WHO) for deficiency, insufficiency, normal, and elevated levels, a significant effect was 
seen for serum folate less than 6.2 nmol/L, the cutoff for deficiency for the WHO (Wald 
X2= 8.59, P<0.0034). When re-stratified to those above and those below 6.2 nmol/L, no 
effect was seen. No other level of serum folate was a significant predictor of the masking 
effect in the post-fortification era. Serum creatinine was not significant in the global 
model, nor when stratified to those above and below 1.1 mg/L, the upper cutoff for 
normal creatinine levels in women, nor when stratified above or below1.3 mg/L, the 
upper cut off for men.
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CHAPTER V 
 
DISCUSSION AND CONCLUSION 
 
Association between the masking effect, fortification, and confounders 
This was the first epidemiological investigation into the direct association the 
masking effect of B-12 deficiency between the pre- and post folic acid fortification 
populations using NHANES data. Serum folate levels have significantly increased in the 
post-fortification period compared to the pre-fortification group, in accord with current 
literature.8,10 The United States Institute of Medicine (IOM) reviewed potential adverse 
effects of increased intake of folic acid prior to the fortification mandate in January 1998. 
From this investigation the IOM found that the only potential risk associated with 
increased serum folate was the potential masking effect of vitamin B-12 deficiency. 
Despite the risk of masking B-12 deficiency, folic acid fortification was mandated for 
processed grains in the United States effective January 1st 1998. The result of this 
program reduced neural tube defects in the United States by as much as 19%.4 Other 
fortification programs have see similar results, including in Chile which saw a decrease in 
incidence of NTDs by 50%, from 17.1 to 8.6/100,000 live births.29 
 The prevalence of those with serum B-12 <148 pmol/L was 2.49%, and prevalence of 
those who met the criteria for the presence of the masking effect was 2.26% in the 
combined NHANES sample population. The proportion of those who met criteria for the
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masking effect increased from 1.81% in the pre-fortification period to 2.43% in the post-
fortification era. The weighted proportions also saw an increase in the post fortification 
era, from 2.05% to 2.32%, however this was not a statistically significant increase (KSa = 
0.87, P<0.4374). Therefore, we reject the hypothesis that the prevalence of the masking 
effect has significantly increased in the post-fortification period. Despite this, the 
weighted sub-sample population who met the criteria for the masking effect was 
representative of over 1.4 million individuals in the post-fortification period at risk of the 
potential deleterious effects associated with undiagnosed vitamin B-12 deficiency. While 
this is not a definitive prevalence rate it is indicative of the need for further study, as this 
is a substantial estimated population at risk. 
The main findings of this study, no significant increase in the masking effect in 
the post-fortification period, contradict that of Wyckoff and Ganji (2007), which found a 
significant increase in the proportion of those with low serum B-12 without macrocytosis. 
However, difference in selection and size of the study populations, cut-off value for B-12 
deficiency and between the two studies could account for this difference in outcome. In 
their study, Wyckoff and Ganji compiled data from patients at Rush Medical University 
Hospital Despite versus this study’s use of NHANES population-wide random, stratified 
clustered sampling. Additionally, the cutoff value for low serum B-12 in their study was 
set at a more liberal 258 pmol/L, versus the more conservative 148 pmol/L used in this 
study.  
 Mills et al (2003), in their investigation into the temporal effect of folic acid 
fortification, found that the proportion of those with B-12 deficiency without 
macrocytosis did not significantly change between the pre and post-fortification eras, 
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similar to the findings of this study. However, the sample populations differ between the 
two studies in selection methods, as the NHANES is a randomized stratified cluster 
study, whereas Mills et al compiled data from the Veteran’s Affairs Medical Center in 
Washington, DC. Furthermore, the cut-off value to denote B-12 deficiency in the Mills 
study was 258 pmol/L versus the more conservative 148 pmol/L used in this study. In 
contradiction to Mills et al (2011), which found none of their sample population 
displayed macrocytosis, 16 individuals were identified as displaying macrocytosis in this 
study. When low serum folate levels were taken into account, 14 individuals remained, 
indicating true B-12 deficiency. Applying the sample weight indicated that those 14 
individuals were representative of nearly 200,000 in the general population.  
 The final sample population contained a higher proportion of men than women 
than one would expect to see in the general population. The youngest age included in 
analysis was 17 years, despite inclusion of children in the original dataset. This is due 
primarily to the missing data for alcohol consumption for youth under the legal drinking 
age in the continuous NHANES survey series, as the question was reserved for those of 
legal drinking age. Therefore, those below the drinking age in the continuous NHANES 
were lost to analysis. The NHANES survey design intentionally over-samples certain 
demographics, however cluster, stratum and sample weight variables were created for 
each individual to accounts for this variation. Hispanic/Mexican Americans were over-
represented in the final sample population when compared to the general population, 
comprising 23.6% of the combined NHANES sample population.  
The shift in education status indicates that a larger proportion of individuals 
attending college in the post-fortification era. Interestingly, smokers comprised nearly 
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49% of the total sample population, which is substantially higher that is seen in the 
general population estimates reported by the Centers for Disease Control and Prevention 
(CDC).30 Alcohol consumption was heavily skewed towards those who consumed more 
than three drinks per day. This could be due to recoding the variables between the 
NHANES III and continuous NHANES series, which differed in the questions related to 
alcohol consumption. The decrease in MCV levels was consistent with the findings of 
Wyckoff and Ganji (2007) from the pre- to post-fortification period. Although 
significantly different, both average MCV levels were within a clinically normal range. 
While in agreement with Wyckoff and Ganji, the lowering of MCV levels in the post-
fortification period contradicts the finding of Hirsh et al (2002) who found an increase in 
MCV after mandatory folic acid fortification of flour in Chile. Lastly serum creatinine 
levels were significantly lower in the post-fortification period, potentially indicating 
better renal function in the post-fortification group. 
Likelihood for the masking effect for the pre and post-fortification era  
 The association of low serum B-12 without macrocytosis and folic acid 
fortification period was significant gender, race/ethnicity, age, and PIR. More 
specifically, and taken as individual predictors, males, non-Hispanic blacks, those who 
were older than 55, and those in the third quartile for PIR in the post-fortification 
population had a higher likelihood of being B-12 deficient with normal MCV compared 
to their pre-fortification counterpart. The findings for the effect of race/ethnicity and age 
are in agreement with those of Wyckoff and Ganji (2007). When age was stratified to 
those above and those at or below 60, neither group proved to be a significant predictor 
of the masking effect. This is discordant with Mills (2003) who found that those aged 
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<65 years were more likely to be B-12 deficient without macrocytosis. Men were more 
likely to meet the criteria for the masking effect in the post fortification period compared 
to men in the pre-fortification period, a similar finding to Wyckoff and Ganji (2007). 
However, the same effect was not seen in women.  
Folic acid was a strong global predictor of the masking effect in the post-
fortification period. However when stratified by serum concentrations defined by the 
WHO as deficient, insufficient, replete, and elevated, the only association between 
fortification periods was seen for folate deficient individuals. When re-stratified to those 
below the deficient cut off and those above, no association across fortification period was 
seen. No effect was seen for the highest strata for serum folate, which is in accord with 
MacFarlane et al (2011) who found those with elevated serum folate were more likely to 
be B-12 replete compared to those with serum folate within the normal range.26 As for 
potential confounding variables, education and alcohol consumption were not found to be 
predictors, and did not contribute to the likelihood of displaying the masking effect in the 
post-fortification period. However, smoking status was a significant predictor. Non-
smokers saw an increased risk of the masking effect in the post-fortification period when 
compared to non-smokers in the pre-fortification era. This effect was not seen in 
smokers. However, this finding should not be taken as a potential protective effect of 
smoking, as cigarette use has been shown to increase the risk of numerous medical issues. 
 For those in the third quartile for PIR, the odds of meeting the criteria for the 
masking effect significantly increased in the post-fortification period versus the pre-
fortification period. Because race/ethnicity has been implicated in increasing the odds of 
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displaying the masking effect in several studies, further investigation into the role 
race/ethnicity plays in B-12 status is warranted.  
Strengths and Limitations 
One of the strengths of this study is that it incorporated a large sample size 
(n=7,242) that provided power to the statistical analysis performed. SAS 9.3 software is a 
newer version that allows for analysis of complex survey designs, like the NHANES. 
This allowed for the adjustment of the analysis to account for the clustering and 
stratification of the survey design and the intentional over-sampling of certain 
demographics that occur within the NHANES surveys. Another strength of this study was 
that it was the first epidemiological investigation exclusively into the masking effect of 
folic acid using serum folate, and vitamin B-12 concentrations in conjunction with MCV 
levels as a measure of macrocytic anemia using population-wide data.  
Limitations of this study include the design of NHANES itself. As a cross-
sectional study, analysis of NHANES data cannot produce cause-and-effect relationships. 
SAS 9.3 is newer version of the software, however there is a limited scope to capabilities 
of complex analysis. Although this software is powerful enough to analyze the data, 
NCHS recommends the use of SUDANN for performing logistic regression with 
NHANES surveys data. SUDANN produces the Wald-F statistic, Satterthwaite adjusted-
F, and Satterthwaite X2, whereas SAS only produces the Wald F statistic. However, the 
NHANES analytic guidelines do not make a recommendation as to which test is the best, 
only that the Satterthwaite adjusted F statistic is the more conservative test and, therefore, 
less likely to reject the null than is the Wald F alone. Additionally, supplementation of 
folic acid or vitamin B-12 was not accounted for in the analysis, which likely resulted in 
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the extreme outliers serum concentrations for folate and B-12. Although care was taken, 
coding errors could have occurred when reformatting, scrubbing, or creating new 
variables with the data, which would add error into the analysis.  
Conclusions 
This study investigated the effect of folic acid fortification on the risk of 
presenting with vitamin B-12 deficiency without macrocytosis. Although the proportion 
of those with vitamin B-12 deficiency without macrocytosis increased in the post-
fortification era, the increase was not statistically significant. A significant increase in 
serum folate concentration has occurred in the United States since the introduction of 
mandatory folic acid in processed grains in 1998. However, serum B-12 concentrations 
saw no significant change between pre and post-fortification periods. Compared to the 
pre-fortification period, in the post-fortification era the likelihood of being B-12 deficient 
without macrocytosis was significantly increased for men, non-Hispanic blacks, those 
over the age of 55, and for those in the third quartile for PIR. But the effect for PIR was 
only seen when stratified by quartiles. No effect for PIR was seen when stratified by 
those above and below the third quartile. Although serum folate levels below 6.3 nmol/L 
were found to be significantly associated with the masking effect in the post-fortification 
era, further analysis refuted this evidence. Elevated serum folate levels were not a 
predictor of the masking effect in the post fortification era.  Further investigations are 
warranted into the masking effect, especially as pertains to the impact race/ethnicity may 
have. 	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APPENDIX A 
Tests for Normality 
Tests	  for	  Normality	   
Variable	   Pre-­‐fortification	   Post-­‐fortification	  
	   Test	   Statistic	   p	  Value	   Statistic	   p	  Value	   	  
	   Kolmogorov
-Smirnov 
D Pr > D D Pr > D 	  
Age	    0.102814 <0.0100 0.060172 <0.0100 	  
PIR	    0.102649 <0.0100 0.120898	   <0.0100	   	  
Serum	  B-­12	   	   0.427912	   <0.0100	   0.419876	   <0.0100	   	  
Serum	  Folate	   	   0.427912	   <0.0100	   0.419876	   <0.0100	   	  
Creatinine	   	   0.146886	   <0.0100	   0.197073	   <0.0100	   	  
MCV	   	   0.046294	   <0.0100	   0.062152	   <0.0100	   	  	  	  
Moments	  for	  Variables	  
Variable	   Pre-­‐fortification	   Post-­‐fortification	  
	   Mean	  
(sd)	  
Median	   IQR	   Kurtosis	   Mean	  
(sd)	  
Median	   IQR	   Kurtosis	  
	   	   	   	   	   	   	   	   	  
Age	   43.43	  (16.74)	   40.0	   26.00	   -­‐0.5933	   48.21	  (17.71)	   47.00	   29.00	   -­‐0.9559	  
PIR	   2.39	  (1.56)	   2.02	   2.65	   -­‐1.1059	   2.73	  (1.62)	   2.53	   3.16	   -­‐1.3980	  
Serum	  B-­
12	  
425.67	  (1898)	   327.21	   173.76	   1241.39	   407.46	  (1612)	   332.10	  	   183.0	   3967.84	  
Serum	  
Folate	  
14.43	  (12.12)	   10.90	   9.50	   48.3557	   31.03	  (20.15)	   26.30	   19.10	   42.9050	  
Serum	  
Creatinine	  
1.09	  (0.22)	   1.10	   0.20	   20.3800	   0.88	  (0.39)	   0.80	   0.30	   328.1877	  
MCV	   89.78	  (5.26)	   89.95	   6.20	   2.3079	   91.23	  (5.29)	   91.40	   5.90	   3.9442	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APPENDIX B 
Two-sample Tests 
 
Kolmogorov-Smirnov Test for Serum Folate 
Classified by Variable PREPOST 
PREPOST N EDF at 
Maximum 
Deviation from Mean 
at Maximum 
Pre-fortification 1936 0.697314 18.384663 
Post-fortification 5306 0.127026 -11.105157 
Total 7242 0.279481   
Maximum Deviation Occurred at Observation 
1818 
Value of FOPSI at Maximum = 15.0 
 
Kolmogorov-Smirnov Two-Sample Test 
(Asymptotic) 
KS 0.252390 D 0.570288 
KSa 21.478369 Pr > KSa <.0001 
………………………………………………………………………………………………………………… 
Kolmogorov-Smirnov Test for Serum B-12 
Classified by Variable PREPOST 
PREPOST N EDF at 
Maximum 
Deviation from Mean 
at Maximum 
Pre-fortification 1936 0.104339 -0.743529 
Post-fortification 5306 0.127403 0.449125 
Total 7242 0.121237   
Maximum Deviation Occurred at Observation 
3686 
Value of VBPSI at Maximum = 206.640 
 
Kolmogorov-Smirnov Two-Sample Test 
(Asymptotic) 
KS 0.010207 D 0.023064 
KSa 0.868647 Pr > KSa 0.4374 
	  	   48	  
………………………………………………………………………………………………………………… 
The NPAR1WAY Procedure 
Kolmogorov-Smirnov Test for Serum Creatinine 
Classified by Variable PREPOST 
PREPOST N EDF at 
Maximum 
Deviation from Mean 
at Maximum 
0 1936 0.244318 -14.026581 
1 5306 0.679420 8.472681 
Total 7242 0.563104   
Maximum Deviation Occurred at Observation 
3598 
Value of CEP at Maximum = 0.90 
 
Kolmogorov-Smirnov Two-Sample Test 
(Asymptotic) 
KS 0.192561 D 0.435101 
KSa 16.386925 Pr > KSa <.0001 
………………………………………………………………………………………………………………… 
The NPAR1WAY Procedure 
Kolmogorov-Smirnov Test for PIR 
Classified by Variable PREPOST 
PREPOST N EDF at 
Maximum 
Deviation from Mean 
at Maximum 
0 1936 0.729855 3.302811 
1 5306 0.627403 -1.995045 
Total 7242 0.654791   
Maximum Deviation Occurred at Observation 
1378 
Value of DMPPIR at Maximum = 3.3520 
 
Kolmogorov-Smirnov Two-Sample Test 
(Asymptotic) 
KS 0.045342 D 0.102452 
KSa 3.858596 Pr > KSa <.0001 
………………………………………………………………………………………………………………… 
The NPAR1WAY Procedure 
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Kolmogorov-Smirnov Test for AGE 
Classified by Variable PREPOST 
PREPOST N EDF at 
Maximum 
Deviation from Mean 
at Maximum 
0 1936 0.612087 5.022953 
1 5306 0.456276 -3.034088 
Total 7242 0.497929   
Maximum Deviation Occurred at Observation 
3643 
Value of HSAGEIR at Maximum = 44.0 
 
Kolmogorov-Smirnov Two-Sample Test 
(Asymptotic) 
KS 0.068957 D 0.155811 
KSa 5.868198 Pr > KSa <.0001 
........................................................................................................................................................... 
The NPAR1WAY Procedure 
Kolmogorov-Smirnov Test for MCV 
Classified by Variable PREPOST 
PREPOST N EDF at 
Maximum 
Deviation from Mean 
at Maximum 
0 1936 0.605888 4.610486 
1 5306 0.462872 -2.784939 
Total 7242 0.501105   
Maximum Deviation Occurred at Observation 
1918 
Value of MVPSI at Maximum = 91.050 
 
Kolmogorov-Smirnov Two-Sample Test 
(Asymptotic) 
KS 0.063294 D 0.143016 
KSa 5.386322 Pr > KSa <.0001 
………………………………………………………………………………………………………………… 
The NPAR1WAY Procedure 
Kolmogorov-Smirnov Test for Level of Education 
Classified by Variable PREPOST 
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PREPOST N EDF at 
Maximum 
Deviation from Mean 
at Maximum 
Pre-fortification 1936 0.700413 5.257839 
Post-fortification 5306 0.537316 -3.175970 
Total 7242 0.580917   
Maximum Deviation Occurred at Observation 
3554 
Value of N3_Edu at Maximum = 2.0 
 
Kolmogorov-Smirnov Two-Sample Test 
(Asymptotic) 
KS 0.072181 D 0.163097 
KSa 6.142610 Pr > KSa <.0001 
………………………………………………………………………………………………………………… 
 The NPAR1WAY Procedure 
Kolmogorov-Smirnov Test for Gender 
Classified by Variable PREPOST 
PREPOST N EDF at 
Maximum 
Deviation from Mean 
at Maximum 
Pre-fortification 1936 0.625000 0.797432 
Post-fortification 5306 0.600264 -0.481684 
Total 7242 0.606877   
Maximum Deviation Occurred at Observation 
3601 
Value of HSSEX at Maximum = 1.0 
 
Kolmogorov-Smirnov Two-Sample Test 
(Asymptotic) 
KS 0.010947 D 0.024736 
KSa 0.931621 Pr > KSa 0.3506 
………………………………………………………………………………………………………………… 
The NPAR1WAY Procedure 
Kolmogorov-Smirnov Test for Stratified Age 
Classified by Variable PREPOST 
PREPOST N EDF at 
Maximum 
Deviation from Mean 
at Maximum 
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Kolmogorov-Smirnov Test for Stratified Age 
Classified by Variable PREPOST 
PREPOST N EDF at 
Maximum 
Deviation from Mean 
at Maximum 
Pre-fortification 1936 0.487087 4.067554 
Post-fortification 5306 0.360912 -2.456984 
Total 7242 0.394642   
Maximum Deviation Occurred at Observation 
3620 
Value of Age_strat at Maximum = 2.0 
 
Kolmogorov-Smirnov Two-Sample Test 
(Asymptotic) 
KS 0.055841 D 0.126175 
KSa 4.752028 Pr > KSa <.0001 
………………………………………………………………………………………………………………… 
The NPAR1WAY Procedure 
Kolmogorov-Smirnov Test for Alcohol 
Classified by Variable PREPOST 
PREPOST N EDF at 
Maximum 
Deviation from Mean 
at Maximum 
Pre-fortification 1936 0.416839 -4.145144 
Post-fortification 5306 0.545420 2.503852 
Total 7242 0.511047   
Maximum Deviation Occurred at Observation 
3749 
Value of Alcohol at Maximum = 2.0 
 
Kolmogorov-Smirnov Two-Sample Test 
(Asymptotic) 
KS 0.056906 D 0.128581 
KSa 4.842675 Pr > KSa <.0001 
………………………………………………………………………………………………………………… 
The NPAR1WAY Procedure 
Kolmogorov-Smirnov Test for Smoke 
Classified by Variable PREPOST 
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PREPOST N EDF at 
Maximum 
Deviation from Mean 
at Maximum 
0 1936 0.570764 2.451388 
1 5306 0.494723 -1.480748 
Total 7242 0.515051   
Maximum Deviation Occurred at Observation 
3644 
Value of smoke at Maximum = 1.0 
 
Kolmogorov-Smirnov Two-Sample Test 
(Asymptotic) 
KS 0.033653 D 0.076042 
KSa 2.863899 Pr > KSa <.0001 
………………………………………………………………………………………………………………… 
The NPAR1WAY Procedure 
Kolmogorov-Smirnov Test for Variable Masking 
Classified by Variable PREPOST 
PREPOST N EDF at 
Maximum 
Deviation from Mean 
at Maximum 
Pre-fortification 1936 0.018079 -0.200955 
Post-fortification 5306 0.024312 0.121386 
Total 7242 0.022646   
Maximum Deviation Occurred at Observation 
3554 
Value of Masking at Maximum = 1.0 
 
Kolmogorov-Smirnov Two-Sample Test 
(Asymptotic) 
KS 0.002759 D 0.006234 
KSa 0.234771 Pr > KSa 1.0000 
 
 	  
